Drug Profile
EradicAide
Alternative Names: EradicAideLatest Information Update: 24 Oct 2021
Price :
$50
*
At a glance
- Originator University of Texas M. D. Anderson Cancer Center
- Class AIDS vaccines
- Mechanism of Action Immunostimulants
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued HIV infections
Most Recent Events
- 25 Jan 2007 Discontinued - Preclinical for HIV infections prevention in USA (PO)
- 25 Jan 2007 Discontinued - Preclinical for HIV infections treatment in France (Injection)
- 25 Jan 2007 Discontinued - Preclinical for HIV infections treatment in USA (Injection)